×
Avantor Inventory 2018-2024 | AVTR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Avantor inventory for the quarter ending September 30, 2024 was
$0.780B
, a
8.31% decline
year-over-year.
Avantor inventory for 2023 was
$0.828B
, a
9.35% decline
from 2022.
Avantor inventory for 2022 was
$0.914B
, a
4.76% increase
from 2021.
Avantor inventory for 2021 was
$0.872B
, a
17.9% increase
from 2020.
View More
Avantor Inventory 2018-2024 | AVTR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Avantor inventory for 2023 was
$0.828B
, a
9.35% decline
from 2022.
Avantor inventory for 2022 was
$0.914B
, a
4.76% increase
from 2021.
Avantor inventory for 2021 was
$0.872B
, a
17.9% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$93.4B
Cencora (COR)
$48.3B
DiDi Global (DIDIY)
$22.2B
Natera (NTRA)
$22.1B
ICON (ICLR)
$17.7B
Viatris (VTRS)
$16B
Revvity (RVTY)
$13.6B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$12.2B
BioMerieux (BMXMF)
$11.9B
Medpace Holdings (MEDP)
$10.5B
Charles River Laboratories (CRL)
$10B
HealthEquity (HQY)
$9.1B
Doximity (DOCS)
$9B
Sonic Healthcare (SKHHY)
$8.9B
Bausch + Lomb (BLCO)
$6.9B
Life Times (LTH)
$5.1B
Organon (OGN)
$3.9B
Sotera Health (SHC)
$3.6B
BrightSpring Health Services (BTSG)
$3.3B
Surgery Partners (SGRY)
$2.9B
Concentras Parent (CON)
$2.8B
PACS (PACS)
$2.5B
Alignment Healthcare (ALHC)
$2.3B
Ardent Health Partners (ARDT)
$2.3B
Premier (PINC)
$2.2B
GeneDx Holdings (WGS)
$2.2B
Ryman Healthcare (RYHTY)
$2B
GoodRx Holdings (GDRX)
$1.9B
Teladoc Health (TDOC)
$1.8B